Cancer patients did not differ from controls in terms of BMI (kg/m2) (26.9 ± 3.3 vs 28.0 ± 4.3, p = 0.375), as well as in median C-reactive protein levels (mg/dL) (0.96 vs 0.27, p = 0.09). The gene discussed is CRP; the disease is cancer.